GURUFOCUS.COM » STOCK LIST » Healthcare » Drug Manufacturers » Hainan Shuangcheng Pharmaceuticals Co Ltd (SZSE:002693) » Definitions » Deferred Policy Acquisition Costs

Hainan Shuangcheng Pharmaceuticals Co (SZSE:002693) Deferred Policy Acquisition Costs


View and export this data going back to 2012. Start your Free Trial

What is Hainan Shuangcheng Pharmaceuticals Co Deferred Policy Acquisition Costs?

Deferred Policy Acquisition Costs only applies to banks and insurance companies.


Hainan Shuangcheng Pharmaceuticals Co (SZSE:002693) Business Description

Traded in Other Exchanges
N/A
Address
16 Xingguo Road, Xiuying District, Haikou, CHN, 570311
Hainan Shuangcheng Pharmaceuticals Co Ltd is engaged in the research, development, and sales of synthesized peptide drugs.
Executives
Yuan Jian Lin Executives
Zhang Wei Executives
Yu Xiao Feng Directors, executives
Wang Xu Guang Executives
Directors, executives
Wang Cheng Dong Directors, executives
Executives
Hu Yi Securities Affairs Representative